Identification of Genes Predicting Poor Response of Trastuzumab in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

OBJECTIVE: To identify trastuzumab-resistant genes predicting drug response and poor prognosis in human epidermal growth factor receptor 2 positive (HER2+) breast cancer. METHODS: Gene expression profiles from the GEO (Gene Expression Omnibus) database were obtained and analyzed. Differentially expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xinrui, Dai, Huijuan, Sun, Aijun, Yu, Zhenfeng, Du, Yueyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348965/
https://www.ncbi.nlm.nih.gov/pubmed/35935587
http://dx.doi.org/10.1155/2022/9529114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348965/
https://www.ncbi.nlm.nih.gov/pubmed/35935587
http://dx.doi.org/10.1155/2022/9529114

Ejemplares similares